Pfizer Inc.
Solid dosage forms of palbociclib
Last updated:
Abstract:
The present invention relates to solid dosage forms of palbociclib comprising a water-soluble acid. The dosage forms described herein have desirable pharmacokinetic characteristics.
Status:
Grant
Type:
Utility
Filling date:
24 May 2016
Issue date:
20 Jul 2021